| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 0.93▲ | 0.93▲ | 0.92▲ | 0.84▲ | 0.82▲ |
| MA10 | 0.89▲ | 0.88▲ | 0.87▲ | 0.82▲ | 0.79▲ |
| MA20 | 0.85▲ | 0.84▲ | 0.83▲ | 0.80▲ | 0.82▲ |
| MA50 | 0.81▲ | 0.81▲ | 0.80▲ | 0.77▲ | 1.03▼ |
| MA100 | 0.80▲ | 0.79▲ | 0.80▲ | 0.82▲ | 1.15▼ |
| MA200 | 0.79▲ | 0.79▲ | 0.76▲ | 1.00▼ | 2.65▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.012▲ | 0.014▲ | 0.015▲ | 0.011▲ | 0.029▲ |
| RSI | 77.959▲ | 76.196▲ | 77.761▲ | 68.948▲ | 53.486▲ |
| STOCH | 93.973▲ | 94.911▲ | 94.130▲ | 65.280 | 61.479 |
| WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -4.348▲ | -10.204▲ |
| CCI | 101.661▲ | 110.779▲ | 130.559▲ | 269.260▲ | 139.016▲ |
|
Friday, June 13, 2025 06:12 AM
Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma” or the “Company”), a clinical-stage biopharmaceutical company focused on transforming acute and chronic care of ...
|
|
Friday, June 13, 2025 06:00 AM
Rademikibart significantly improved lung function and asthma control in patients with eosinophilic-driven type 2 asthma – – Rademikibart reduced annualized exacerbations in patients with ...
|
|
Monday, June 09, 2025 05:00 PM
SAN DIEGO, June 03, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma” or the “Company”), a clinical-stage biopharmaceutical company focused on ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 13/06/25 | 0.848 | 0.96 | 0.848 | 0.95 | 457,663 |
| 12/06/25 | 0.83 | 0.88 | 0.79 | 0.85 | 107,580 |
| 11/06/25 | 0.80 | 0.82 | 0.78 | 0.819 | 21,334 |
| 10/06/25 | 0.8016 | 0.8095 | 0.7873 | 0.7873 | 24,616 |
| 09/06/25 | 0.77 | 0.8169 | 0.7527 | 0.781 | 33,108 |
| 06/06/25 | 0.77 | 0.82 | 0.77 | 0.7915 | 28,228 |
| 05/06/25 | 0.788 | 0.7999 | 0.755 | 0.7801 | 24,126 |
| 04/06/25 | 0.80 | 0.83 | 0.73 | 0.7714 | 82,150 |
| 03/06/25 | 0.84 | 0.8408 | 0.81 | 0.811 | 21,817 |
| 02/06/25 | 0.82 | 0.8498 | 0.798 | 0.8193 | 41,183 |
|
|
||||
|
|
||||
|
|